Pusceddu, C.;                     De Francesco, D.;                     Melis, L.;                     Ballicu, N.;                     Fancellu, A.    
        The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases. Curr. Oncol. 2021, 28, 4004-4015.
    https://doi.org/10.3390/curroncol28050340
    AMA Style
    
                                Pusceddu C,                                 De Francesco D,                                 Melis L,                                 Ballicu N,                                 Fancellu A.        
                The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases. Current Oncology. 2021; 28(5):4004-4015.
        https://doi.org/10.3390/curroncol28050340
    
    Chicago/Turabian Style
    
                                Pusceddu, Claudio,                                 Davide De Francesco,                                 Luca Melis,                                 Nicola Ballicu,                                 and Alessandro Fancellu.        
                2021. "The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases" Current Oncology 28, no. 5: 4004-4015.
        https://doi.org/10.3390/curroncol28050340
    
    APA Style
    
                                Pusceddu, C.,                                 De Francesco, D.,                                 Melis, L.,                                 Ballicu, N.,                                 & Fancellu, A.        
        
        (2021). The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases. Current Oncology, 28(5), 4004-4015.
        https://doi.org/10.3390/curroncol28050340